Distribution of each biomarker, such as RRS, age, sex, race, tumor histology, tumor stage, PD-L1 expression, and smoking status, based on low-risk and high-risk groups
Biomarker | High-risk | Low-risk | P value |
RRS | Median=0.47 95% CI 0.53 to 0.92 | Median=0.6 95% CI −0.87 to −0.59 | 1.14e-21 |
PD-L1 | 8 high PD-L1 38 low PD-L1 14 N/A | 25 high PD-L1 23 low PD-L1 11 N/A | 0.0012 |
Smoking | 16 current smoker 45 never or former | 18 current smoker 41 never or former | 0.68 |
Pack per year | Median=45.5 95% CI 42.6 to 56.9 | Median=42 95% CI 38.55 to 51.27 | 0.32 |
Age | Median=66 95% CI 64.8 to 68.6 | Median=69 95% CI 67.23 to 71.95 | 0.63 |
Sex | 23 male 28 female | 28 male 31 female | 0.58 |
Race | 49 white 11 black | 46 white 13 black | 0.65 |
Tumor histology | 28 squamous 27 adenocarcinoma 5 large cell carcinoma | 27 squamous 32 adenocarcinoma 1 large cell carcinoma | 0.24 |
Stage | 25 stage IIIA 32 stage IIIB 3 stage IIIC | 29 stage IIIA 27 stage IIIB 3 stage IIIC | 0.72 |
N/A, not available; PD-L1, programmed cell death ligand-1; RRS, radiomic signature risk score.